{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T14:33:48Z","timestamp":1788878028240,"version":"build-2803163510"},"reference-count":32,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"25","license":[{"start":{"date-parts":[[2025,6,20]],"date-time":"2025-06-20T00:00:00Z","timestamp":1750377600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"the National Natural Science Foundation of China","doi-asserted-by":"crossref","award":["No. 82300959"],"award-info":[{"award-number":["No. 82300959"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Scientific Research Foundation provided by Pudong Hospital affiliated to Fudan University","award":["Project no.YJYJRC202109"],"award-info":[{"award-number":["Project no.YJYJRC202109"]}]},{"name":"Talents Training Program of Pudong Hospital affiliated to Fudan University","award":["Project no.YQ2022-02"],"award-info":[{"award-number":["Project no.YQ2022-02"]}]},{"name":"the Project of Key Medical Specialty and Treatment Center of Pudong Hospital of Fudan University","award":["Grant No. Zdzk2020-23"],"award-info":[{"award-number":["Grant No. Zdzk2020-23"]}]},{"name":"the Key Discipline Construction Project of Pudong Health and Family Planning Commission of Shanghai","award":["Grant No. PWZxk2022-08"],"award-info":[{"award-number":["Grant No. PWZxk2022-08"]}]},{"name":"Pudong New Area Health System Outstanding Young Medical Talents Project","award":["PWRq2024-06"],"award-info":[{"award-number":["PWRq2024-06"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2025,6,20]]},"abstract":"<jats:p>\n                    Biological agents are frontline treatments for ankylosing spondylitis (AS) and rheumatoid arthritis (RA); however, their efficacy varies owing to differences in patient autoimmune status. This study aimed to evaluate peripheral blood cytokine profiles in patients with AS and RA and assess the impact of different treatment modalities. Data from 145 patients with AS, 491 patients with RA, and 125 healthy controls were collected. Cytokine levels (tumor necrosis factor [TNF]-\u03b1, interleukin [IL]-6, IL-8, IL-17, IL-5, etc) were analyzed in healthy controls and patients with AS and RA, with a focus on patients with AS treated with or without biologics. The effects of biologic therapy on cytokine levels in patients with AS and RA were evaluated, along with the impact of disease-modifying antirheumatic drug (DMARD) monotherapy or combination therapy with biologics in patients with RA. Significant differences in interferon (IFN)-\u03b1, IFN-\u03b3, IL-10, IL-12P70, IL-2, IL-4, IL-5, IL-6, IL-8, TNF-\u03b1, and IL-1\u03b2 were found among the AS, RA, and HC groups (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005&lt;\u2005.001); however, no significant difference was noted in IL-17A levels. In patients with RA treated with biologics, IL-1\u03b2 levels significantly increased (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.013). In patients with AS treated with biologics, TNF-\u03b1 levels were correlated with IL-6 and IL-8 levels, and IL-17A levels were correlated with IL-5 and IL-8 levels. Combination therapy with DMARDs and biologics significantly increased IL-1\u03b2 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.016) and IL-6 (\n                    <jats:italic toggle=\"yes\">P<\/jats:italic>\n                    \u2005=\u2005.047) levels in patients with RA. Overall, biological agents affect cytokine levels in patients with AS and RA, and combination therapy with DMARDs upregulates these levels. Drug choice and combination may significantly influence treatment outcomes in patients with AS and RA treated with biological agents.\n                  <\/jats:p>","DOI":"10.1097\/md.0000000000042953","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T17:00:10Z","timestamp":1750698010000},"page":"e42953","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":5,"title":["Relationship between biologic therapy and cytokine levels in patients with inflammatory arthritis"],"prefix":"10.1097","volume":"104","author":[{"given":"Ze","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bing-He","family":"Zhou","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Hu","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Chao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dong","family":"Chang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-8345-9904","authenticated-orcid":false,"given":"Xin","family":"Dou","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Shanghai Pudong Hospital, Fudan University, Shanghai, China."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20260613","doi-asserted-by":"crossref","first-page":"e003880","DOI":"10.1136\/rmdopen-2023-003880","article-title":"Metabolic and molecular imaging in inflammatory arthritis.","volume":"10","author":"Noversa de Sousa","year":"2024","journal-title":"RMD Open"},{"key":"R2-20260613","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.medcli.2023.07.014","article-title":"Rheumatoid arthritis.","volume":"161","author":"D\u00edaz-Gonz\u00e1lez","year":"2023","journal-title":"Med Clin (Barc)"},{"key":"R3-20260613","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41584-021-00625-y","article-title":"Ankylosing spondylitis: an autoimmune or autoinflammatory disease?","volume":"17","author":"Mauro","year":"2021","journal-title":"Nat Rev Rheumatol"},{"key":"R5-20260613","doi-asserted-by":"crossref","first-page":"462","DOI":"10.18502\/jovr.v16i3.9440","article-title":"Ankylosing spondylitis.","volume":"16","author":"Ebrahimiadib","year":"2021","journal-title":"J Ophthalmic Vis Res"},{"key":"R6-20260613","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1038\/s41584-023-01009-0","article-title":"Innate immune memory in inflammatory arthritis.","volume":"19","author":"Jeljeli","year":"2023","journal-title":"Nat Rev Rheumatol"},{"key":"R7-20260613","doi-asserted-by":"crossref","first-page":"10922","DOI":"10.3390\/ijms222010922","article-title":"Cytokine networks in the pathogenesis of rheumatoid arthritis.","volume":"22","author":"Kondo","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R8-20260613","doi-asserted-by":"crossref","first-page":"220","DOI":"10.4078\/jrd.2023.0041","article-title":"Updates on ankylosing spondylitis: pathogenesis and therapeutic agents.","volume":"30","author":"Kim","year":"2023","journal-title":"J Rheum Dis"},{"key":"R9-20260613","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11010-022-04492-3","article-title":"Rheumatoid arthritis: advances in treatment strategies.","volume":"478","author":"Prasad","year":"2023","journal-title":"Mol Cell Biochem"},{"key":"R10-20260613","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.3390\/jcm12041630","article-title":"Past, present and (Foreseeable) future of biological Anti-TNF alpha therapy.","volume":"12","author":"Leone","year":"2023","journal-title":"J Clin Med"},{"key":"R11-20260613","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.3390\/ijms22052719","article-title":"The role of tumor necrosis factor alpha (TNF-\u03b1) in autoimmune disease and current TNF-\u03b1 inhibitors in therapeutics.","volume":"22","author":"Jang","year":"2021","journal-title":"Int J Mol Sci"},{"key":"R12-20260613","doi-asserted-by":"crossref","first-page":"638444","DOI":"10.3389\/fimmu.2021.638444","article-title":"Efficacy and safety of adalimumab biosimilars: current critical clinical data in rheumatoid arthritis.","volume":"12","author":"Lu","year":"2021","journal-title":"Front Immunol"},{"key":"R13-20260613","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/1744666X.2019.1705785","article-title":"Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics.","volume":"16","author":"Chiu","year":"2020","journal-title":"Expert Rev Clin Immunol"},{"key":"R14-20260613","doi-asserted-by":"crossref","first-page":"108402","DOI":"10.1016\/j.intimp.2021.108402","article-title":"The role of IL-17 and anti-IL-17 agents in the immunopathogenesis and management of autoimmune and inflammatory diseases.","volume":"102","author":"Berry","year":"2022","journal-title":"Int Immunopharmacol"},{"key":"R15-20260613","doi-asserted-by":"crossref","first-page":"7100","DOI":"10.3390\/ijms21197100","article-title":"Blocking IL-17: a promising strategy in the treatment of systemic rheumatic diseases.","volume":"21","author":"Rafael-Vidal","year":"2020","journal-title":"Int J Mol Sci"},{"key":"R16-20260613","first-page":"e33293","article-title":"The role of biologics in rheumatoid arthritis: a narrative review.","volume":"15","author":"Patel","year":"2023","journal-title":"Cureus"},{"key":"R17-20260613","doi-asserted-by":"crossref","first-page":"108793","DOI":"10.1016\/j.clim.2021.108793","article-title":"Recent advances on signaling pathways and their inhibitors in rheumatoid arthritis.","volume":"230","author":"Liu","year":"2021","journal-title":"Clin Immunol"},{"key":"R18-20260613","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1146\/annurev-immunol-101819-025146","article-title":"Dendritic cell regulation of T helper cells.","volume":"39","author":"Yin","year":"2021","journal-title":"Annu Rev Immunol"},{"key":"R19-20260613","doi-asserted-by":"crossref","first-page":"744254","DOI":"10.3389\/fimmu.2021.744254","article-title":"Elevated peripheral T helper cells are associated with atrial fibrillation in patients with rheumatoid arthritis.","volume":"12","author":"Wang","year":"2021","journal-title":"Front Immunol"},{"key":"R20-20260613","doi-asserted-by":"crossref","first-page":"867260","DOI":"10.3389\/fimmu.2022.867260","article-title":"The Role of M1\/M2 macrophage polarization in rheumatoid arthritis synovitis.","volume":"13","author":"Cutolo","year":"2022","journal-title":"Front Immunol"},{"key":"R21-20260613","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/art.41666","article-title":"Characterization and function of tumor necrosis factor and interleukin-6-induced osteoclasts in rheumatoid arthritis.","volume":"73","author":"Yokota","year":"2021","journal-title":"Arthritis Rheumatol"},{"key":"R22-20260613","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41584-018-0109-2","article-title":"Anti-inflammatory and immune-regulatory cytokines in rheumatoid arthritis.","volume":"15","author":"Chen","year":"2019","journal-title":"Nat Rev Rheumatol"},{"key":"R23-20260613","doi-asserted-by":"crossref","first-page":"3000","DOI":"10.3390\/cells10113000","article-title":"Significance of interleukin (IL)-4 and IL-13 in inflammatory arthritis.","volume":"10","author":"Iwaszko","year":"2021","journal-title":"Cells"},{"key":"R24-20260613","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1093\/bbb\/zbab099","article-title":"Ginsenoside Rh1 attenuates ovalbumin-induced asthma by regulating Th1\/Th2 cytokines balance.","volume":"85","author":"Li","year":"2021","journal-title":"Biosci Biotechnol Biochem"},{"key":"R25-20260613","doi-asserted-by":"crossref","first-page":"106187","DOI":"10.1016\/j.intimp.2020.106187","article-title":"Molecular control of pathogenic Th17 cells in autoimmune diseases.","volume":"80","author":"Wu","year":"2020","journal-title":"Int Immunopharmacol"},{"key":"R26-20260613","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3904\/kjim.2018.364","article-title":"Effect of biologics in the level of cytokines in the synovial fluid of patients with ankylosing spondylitis.","volume":"35","author":"Koo","year":"2020","journal-title":"Korean J Intern Med"},{"key":"R27-20260613","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.2174\/1381612829666230904150808","article-title":"Role of Th17 and IL-17 cytokines on inflammatory and auto-immune diseases.","volume":"29","author":"Akhter","year":"2023","journal-title":"Curr Pharm Des"},{"key":"R28-20260613","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/labmed\/lmab029","article-title":"Serum IL-6 and TNF-\u03b1 Levels are correlated with disease severity in patients with ankylosing spondylitis.","volume":"53","author":"Du","year":"2022","journal-title":"Lab. Med"},{"key":"R29-20260613","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1177\/1759720X16665330","article-title":"Combination therapy with biologic agents in rheumatic diseases: current and future prospects.","volume":"8","author":"Inui","year":"2016","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"R30-20260613","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1080\/14712598.2021.1847268","article-title":"Tailoring biologic therapy for real-world rheumatoid arthritis patients.","volume":"21","author":"Romano","year":"2021","journal-title":"Expert Opin Biol Ther"},{"key":"R31-20260613","first-page":"e52559","article-title":"Diagnosis and treatment of ankylosing spondylitis.","volume":"16","author":"Agrawal","year":"2024","journal-title":"Cureus"},{"key":"R32-20260613","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1136\/annrheumdis-2013-204436","article-title":"Prevalence of spondyloarthritis in reference to HLA-B27 in the French population: results of the GAZEL cohort.","volume":"74","author":"Costantino","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"R33-20260613","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1136\/ard.2009.126532","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs.","volume":"69","author":"Smolen","year":"2010","journal-title":"Ann Rheum Dis"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042953","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,13]],"date-time":"2026-06-13T13:00:14Z","timestamp":1781355614000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MD.0000000000042953"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6,20]]},"references-count":32,"journal-issue":{"issue":"25","published-print":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0000000000042953","relation":{},"ISSN":["1536-5964"],"issn-type":[{"value":"1536-5964","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,6,20]]}}}